Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.

ABSTRACT:

Background

The rapidly increased spending on insulin is a major public health issue in the United States. Industry marketing might be one of the upstream determinants of physicians' prescription of long-acting insulin-the most commonly used and costly type of insulin, but the evidence is lacking. We therefore aimed to investigate the association between industry payments to physicians and subsequent prescriptions of long-acting insulin.

Methods and findings

Using the databases of Open Payments and Medicare Part D, we examined the association between the receipt of industry payments for long-acting insulin in 2016 and (1) the number of claims; (2) the costs paid for all claims; and (3) the costs per claim of long-acting insulin in 2017. We also examined the association betwee

SUBMITTER: Inoue K 

PROVIDER: S-EPMC8205129 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature